A-A-51784A
3 September 1987
SUPERSEDING
A-A-0051784(DM)
11 December 1986
COMMERCIAL ITEM DESCRIPTION
HALOPERIDOL TABLETS, USP
The General Services Administration has authorized the use of this Commercial Item Description.
Salient Characteristics:
Shall be Haloperidol Tablets, USP.
Shall be in accordance with the requirements of the USP.
Materials used in manufacture shall be of pharmaceutical grade.
For Strength 1, shall contain 0.5 mg of Haloperidol per tablet, within the applicable assay limits.
For Strength 2, shall contain 1 mg of Haloperidol per tablet, within the applicable assay limits.
For Strength 3, shall contain 2 mg of Haloperidol per tablet, within the applicable assay limits.
For Strength 4, shall contain 5 mg of Haloperidol per tablet, within the applicable assay limits.
For Strength 5, shall contain 10 mg of Haloperidol per tablet, within the applicable assay limits.
For Strength 6, shall contain 20 mg of Haloperidol per tablet, within the applicable assay limits.
Workmanship. The tablets shall be free from defect which detract from their appearance or impair their serviceability.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business